Fred Ledley’s INET-Funded Research Remains in the Top 5% of all Research Monitored by Altmetric (≈28 million)
Altmetric
Fred Ledley's INET-funded research, which was published as an INET working paper, documents that the US Government is the first investor in practically all crucial biopharmaceutical innovation.